Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Gilead Sciences |
---|---|
Information provided by: | Gilead Sciences |
ClinicalTrials.gov Identifier: | NCT00445146 |
This study is being initiated to provide continued access to GS-9137/r for those subjects currently benefiting from their participation in an ongoing GS-9137/r study. This study will also provide initial access to GS-9137/r for those subjects who have completed a GS-9137/r study in which the subject was participating in a treatment arm that did not include GS-9137/r. This study will continue to monitor the safety and tolerability of GS-9137/r through periodic assessment of adverse events, changes in concomitant medications and clinical laboratory tests. This study is an open-label study.
Condition | Intervention | Phase |
---|---|---|
HIV Infections |
Drug: GS-9137 |
Phase II |
Study Type: | Observational |
Study Design: | Longitudinal, Defined Population, Prospective Study |
Official Title: | A Phase 2, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | GS-US-183-0130 |
Study First Received: | February 28, 2007 |
Last Updated: | April 2, 2007 |
ClinicalTrials.gov Identifier: | NCT00445146 |
Health Authority: | United States: Food and Drug Administration |
Phase 2 Open-label Rollover Integrase Inhibitor Antiretroviral Agents |
Highly Active Antiretroviral Activity HAART HIV, HIV-1, AIDS virus, Human Immunodeficiency Virus Acquired Immune Deficiency Syndrome Virus treatment experienced |
Virus Diseases Sexually Transmitted Diseases, Viral Ritonavir HIV Infections |
Sexually Transmitted Diseases Acquired Immunodeficiency Syndrome Retroviridae Infections Immunologic Deficiency Syndromes |
RNA Virus Infections Slow Virus Diseases Immune System Diseases Lentivirus Infections Infection |